National Health Investors (NHI) Updates FY18 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share guidance of $5.47-5.51 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.50.

A number of research firms recently issued reports on NHI. Wells Fargo & Co reissued a hold rating on shares of National Health Investors in a research note on Tuesday. Zacks Investment Research downgraded shares of National Health Investors from a buy rating to a hold rating in a research note on Tuesday, August 14th. Cantor Fitzgerald reaffirmed a hold rating and set a $75.00 target price on shares of National Health Investors in a research note on Tuesday, May 8th. SunTrust Banks reaffirmed a hold rating and set a $79.00 target price on shares of National Health Investors in a research note on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Stifel Nicolaus set a $83.00 price target on shares of National Health Investors and gave the company a buy rating in a report on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $75.44.

NYSE NHI traded up $0.67 on Friday, reaching $79.25. The company had a trading volume of 161,800 shares, compared to its average volume of 210,002. The company has a debt-to-equity ratio of 0.90, a quick ratio of 15.56 and a current ratio of 15.56. The company has a market cap of $3.33 billion, a P/E ratio of 14.87, a P/E/G ratio of 3.40 and a beta of 0.43. National Health Investors has a 12 month low of $62.71 and a 12 month high of $81.60.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.05). National Health Investors had a net margin of 53.16% and a return on equity of 11.49%. The company had revenue of $72.96 million during the quarter, compared to the consensus estimate of $73.80 million. analysts forecast that National Health Investors will post 5.51 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 9th. Shareholders of record on Friday, September 28th will be paid a $1.00 dividend. The ex-dividend date is Thursday, September 27th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.05%. National Health Investors’s payout ratio is currently 75.05%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Short Selling Stocks, A Beginner’s Guide

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.

Leave a Reply